![]() |
市場調查報告書
商品編碼
1945820
植物藥和針灸市場-全球產業規模、佔有率、趨勢、機會和預測:干預方法、分銷方法、區域和競爭格局,2021-2031年Botanicals & Acupuncture Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Intervention (Botanicals, Acupuncture), By Distribution Method, By Region & Competition, 2021-2031F |
||||||
全球草藥和針灸市場預計將從 2025 年的 448.2 億美元大幅成長到 2031 年的 733.2 億美元,複合年成長率為 8.55%。
該領域涵蓋植物來源療法和傳統針灸療法的商業化和應用,旨在實現整體健康管理。市場擴張的主要驅動力是全球慢性病盛行率的不斷上升,以及消費者對非侵入性、預防性醫療保健方案的明顯偏好,這些方案旨在最大程度地減少對合成藥物的依賴。人口老化也進一步推動了這一趨勢,人們希望透過整合醫學來延年益壽。美國植物委員會 (ABC) 的報告支持了這一成長,該報告稱,預計到 2024 年,美國草藥膳食補充劑的零售額將達到創紀錄的 132.3 億美元,比上一年成長 5.4%。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 448.2億美元 |
| 市場規模:2031年 | 733.2億美元 |
| 複合年成長率:2026-2031年 | 8.55% |
| 成長最快的細分市場 | 針刺 |
| 最大的市場 | 歐洲 |
然而,市場擴張的一大障礙是各國缺乏統一的法規結構和品管標準。植物產品的核准流程和針灸師的執業許可要求各不相同,這嚴重阻礙了國際貿易和人才流動。這種監管碎片化使得跨國公司難以進入市場,可能損害消費者對產品安全性和有效性的信心,並限制了永續產業發展所需的普遍可及性。
慢性病發病率的上升以及對非藥物鎮痛療法日益成長的需求,正在從根本上改變全球植物療法和針灸市場。隨著醫療服務提供者和患者都在尋求替代鴉片類藥物和合成止痛藥的療法來治療骨關節炎和肌肉骨骼疾病等,實證治療方法(如針灸)正迅速普及。這種趨勢的動力源於人們對低風險、有效且符合整體護理框架的干涉措施的需求。例如,美國國家補充與綜合健康中心2024年1月發布的報告《美國成年人補充健康療法總體使用情況及疼痛管理使用情況》顯示,美國成年人使用針灸的比例在20年間成長了一倍多,到2022年達到2.2%。其中,針灸用於疼痛管理的使用者成長尤其顯著。
同時,隨著消費者對預防性保健和潔淨標示療法的興趣日益濃厚,他們越來越傾向於選擇天然和有機保健產品,市場也因此持續擴張。這一趨勢體現在消費者對植物來源成分而非傳統藥物的偏好不斷增強,從而提升了植物萃取物和膳食補充劑的商業性前景。根據責任營養委員會 (CRN) 於 2024 年 10 月發布的《2024 年消費者調查》數據,自 2020 年以來,植物補充劑睡茄的使用量成長了四倍,目前佔膳食補充劑消費者的 8%。此外,全球基礎設施建設也在穩步推進。 2024 年 8 月,世界衛生組織 (WHO) 宣布,印度政府承諾向全球傳統醫學中心提供 8,500 萬美元的資金,凸顯了該領域的國際發展。
國際上不同司法管轄區的法規結構和品管標準存在差異,這仍然是全球草藥療法和針灸市場發展的主要障礙。這種不一致性造成了營運摩擦,阻礙了業界建立統一的全球標準。對於草藥療法生產者而言,應對不同的核准流程增加了遵循成本,並擾亂了供應鏈。同時,針灸師執業許可規則的不一致阻礙了人才流動和治療通訊協定的標準化。這些不一致導致潛在消費者產生疑慮,他們可能認為缺乏統一的監管會對產品的安全性和有效性構成威脅,從而有效地抑制了消費者對產品的信任,而信任是產品被大規模接受所必需的。
此外,監管不統一限制了這些療法融入主流醫療體系,阻礙了全民普及。缺乏標準化的核准導致保險覆蓋範圍狹窄,患者高度依賴自付費用,這使得許多人遠離醫療保健。美國國家針灸及東方醫學認證委員會(NBOCM)的報告凸顯了這個問題,報告指出,由於行政程序和報銷方面的挑戰,到2024年,僅有45%的針灸從業者接受保險。這項數據表明,監管障礙和支付方接受度的不一致直接限制了該行業的擴張,有效地抑制了其發展,即便全球對整體醫療保健的興趣日益成長。
全球草藥和針灸市場正經歷著重大變革時期,草藥產品正朝著直接面對消費者的電子商務模式轉型,這從根本上改變了通路。消費者越來越傾向於選擇提供教育內容和個人化訂閱服務的數位平台,以獲得專業的植物配方。這種數位化提高了原料來源的透明度,並使得數據分析能夠應用於開發針對特定健康益處(例如認知增強)的產品。美國植物委員會 (ABC) 於 2025 年 9 月發布的《2024 年草藥市場報告》也印證了這一管道的主導地位。報告預測,直接面對消費者的銷售額將引領整個零售市場,總值將達到 75 億美元(年成長 6.8%)。
同時,將針灸和植物療法融入養生旅遊套餐,正在創造新的高價值商機。豪華度假村和飯店業者正將傳統中醫和阿育吠陀療法融入生物駭客和長壽療養計畫中,提供超越單純放鬆的實證復健護理。這種融合吸引了追求積極健康最佳化和身臨其境型整體體驗而非被動醫療干預的富裕旅行者。全球健康研究所於2025年12月發布的《2025年全球健康經濟監測報告》反映了這一強勁的需求,預測到2029年,傳統和補充醫學產業將以每年10.8%的速度成長,顯著超過整體經濟成長趨勢。
The Global Botanicals & Acupuncture Market is projected to expand significantly, growing from a valuation of USD 44.82 Billion in 2025 to USD 73.32 Billion by 2031, representing a compound annual growth rate of 8.55%. This sector comprises the commercial trade and utilization of plant-based therapeutic agents and traditional needle-stimulation therapies designed for holistic health management. Market expansion is largely driven by the increasing global prevalence of chronic diseases and a distinct consumer preference for non-invasive, preventive healthcare options that minimize dependence on synthetic drugs. This trend is further bolstered by an aging population seeking functional longevity through integrative medicine. Underscoring this growth, the American Botanical Council reported that retail sales of herbal dietary supplements in the United States hit a record $13.23 billion in 2024, marking a 5.4% rise from the prior year.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 44.82 Billion |
| Market Size 2031 | USD 73.32 Billion |
| CAGR 2026-2031 | 8.55% |
| Fastest Growing Segment | Acupuncture |
| Largest Market | Europe |
Conversely, a major obstacle hindering widespread market growth is the lack of consistent regulatory frameworks and quality control standards among different nations. Discrepancies in approval processes for botanical goods and differing licensure prerequisites for acupuncture professionals establish significant hurdles to seamless international trade and workforce mobility. This regulatory fragmentation makes market entry difficult for multinational entities and risks eroding consumer trust in product safety and effectiveness, thereby limiting the universal accessibility needed for sustained industry development.
Market Driver
The growing incidence of chronic conditions and the intensified search for non-pharmacological pain relief are fundamentally transforming the Global Botanicals & Acupuncture Market. As healthcare providers and patients alike look for alternatives to opioids and synthetic painkillers for ailments like osteoarthritis and musculoskeletal issues, evidence-based treatments such as acupuncture are seeing rapid uptake. This adoption is fueled by a demand for low-risk, effective interventions that fit within holistic care frameworks. Illustrating this shift, a January 2024 report by the National Center for Complementary and Integrative Health titled 'Use of Complementary Health Approaches Overall and for Pain Management by US Adults' revealed that acupuncture usage among U.S. adults more than doubled over two decades, reaching 2.2% in 2022, with a significant number of users specifically seeking pain management.
Concurrently, the market is expanding due to a rising consumer inclination toward natural and organic healthcare products, driven by an interest in preventative wellness and clean-label therapeutics. This movement involves a growing preference for plant-based ingredients over conventional medicines, boosting the commercial prospects of botanical extracts and supplements. Data from the Council for Responsible Nutrition's '2024 Consumer Survey,' released in October 2024, indicates that the use of the botanical supplement Ashwagandha has quadrupled since 2020, now being used by 8% of all supplement consumers. Additionally, global infrastructure is being bolstered; in August 2024, the World Health Organization noted that the Government of India pledged US$ 85 million to the Global Traditional Medicine Centre, underscoring the sector's expanding international scale.
Market Challenge
The disparity in regulatory frameworks and quality control standards across various international jurisdictions remains a central obstacle for the Global Botanicals & Acupuncture Market. This lack of uniformity causes operational friction and prevents the industry from establishing cohesive global norms. For manufacturers of botanicals, dealing with differing approval processes raises compliance expenses and interrupts supply chains, while inconsistent licensure rules for acupuncturists hinder workforce mobility and the standardization of treatment protocols. Such inconsistency generates skepticism among prospective consumers, who may view the lack of unified oversight as a threat to product safety and effectiveness, effectively stifling the trust needed for mass adoption.
Moreover, the absence of regulatory harmonization restricts the integration of these therapies into mainstream financial healthcare systems, thereby limiting universal access. Without standardized recognition, reimbursement options are narrow, leading to a heavy dependence on out-of-pocket payments that alienate large segments of the population. Highlighting this issue, the National Certification Commission for Acupuncture and Oriental Medicine reported in 2024 that only 45% of acupuncture practitioners accepted insurance due to administrative and reimbursement difficulties. This figure demonstrates how regulatory barriers and inconsistent payer acceptance directly limit the sector's expansion, effectively curbing growth despite increasing global interest in holistic health management.
Market Trends
The Global Botanicals & Acupuncture Market is undergoing a significant transformation toward direct-to-consumer e-commerce models for herbal products, which is fundamentally changing distribution channels. Consumers are increasingly skipping traditional retail stores in favor of digital platforms that provide educational content and personalized subscription services for specialized botanical formulas. This shift to digital allows for improved transparency regarding ingredient sourcing and enables brands to use data analytics for product development targeted at specific health outcomes, such as cognitive performance. Underscoring the dominance of this channel, the American Botanical Council's '2024 Herb Market Report' from September 2025 indicated that direct-to-consumer sales topped all retail segments, totaling $7.5 billion and marking a 6.8% rise from the prior year.
At the same time, the incorporation of acupuncture and botanicals into wellness tourism packages is creating new, high-value revenue opportunities. Luxury resorts and hospitality providers are embedding Traditional Chinese Medicine and Ayurvedic treatments into biohacking and longevity retreats, advancing beyond simple relaxation to offer evidence-based restorative care. This convergence attracts affluent travelers looking for proactive health optimization and immersive holistic experiences rather than reactive medical interventions. Reflecting this strong demand, the Global Wellness Institute's 'Global Wellness Economy Monitor 2025', released in December 2025, projects that the Traditional and Complementary Medicine sector will grow at an annual rate of 10.8% through 2029, significantly exceeding broader economic growth trends.
Report Scope
In this report, the Global Botanicals & Acupuncture Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Botanicals & Acupuncture Market.
Global Botanicals & Acupuncture Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: